Earnings Call · Q3 FY2021·2021-11-15

Q3 21EPS +2.10%·Rev n/aQ2 21EPS +30.77%·Rev n/aQ1 21EPS -7.69%·Rev n/aQ4 20EPS -37.87%·Rev n/a⚠ consensus missing

Evofem Biosciences, Inc. EVFM

Amy Raskopf — Investor Relations

Saundra Pelletier — Chief Executive Officer

Jay File — Chief Commercial Officer

−15.6%1d on move date−16.0% vs SPY3d−27.8%5d−27.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EVFM calls or request research access.

More EVFM calls Browse calls Request research access